TP53 mutations, the most common in HCC, have been closely linked to the immune microenvironment, with tumors harboring TP53 alterations exhibiting reduced infiltration of CD3+ T cells and increased infiltration of Foxp53+ Treg cells, leading to immune response downregulation (Hu ZQ. This evidence concerns the gene TP53 and hepatocellular carcinoma.